ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 733981 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 733981; 2) Community: the network communities that were significantly associated with the response to NSC 733981; 3) Molecule: the relationships between components within communities and NSC 733981; 4) MDR: the compounds that were significantly associated with the NSC 733981.

NSC Compound Enrichment Correlation
NSC 328410 Camptothecin Derivative 0.0105244982742819 0.56773793
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0105244982742819 0.40729903
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0105244982742819 0.44255887
NSC 673652 2-Ethylaminoestradiol 0.0105244982742819 0.11196139
NSC 687578 Null 0.0105244982742819 0.36783077
NSC 700363 Liposomal Annamycin 0.0105244982742819 0.60402576
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0105244982742819 0.66114456
NSC 728133 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,5-dichlorobenzene 0.0105244982742819 0.56749946
NSC 748643 Mitaplatin 0.0105244982742821 0.40757929
NSC 83142 Daunorubicin hydrochloride 0.0105607789694647 0.41416278
Total:39  Current:8    [First] [Prev] [Next] [Last]